OneMedNet Corporation

ONMD Healthcare Health Information Services

OneMedNet Corporation’s revenue for fiscal 2025 (year ended December 2025) was $1.4 million, up 111.4% from fiscal 2024. In the quarter to June 2026, revenue grew 88.4%, EPS fell 148.2%, free cash flow grew 14.1% and total debt rose 75.3%, each against the same quarter a year earlier. Insiders bought in the last twelve months.

4.51 0.24 −5.05%
Market cap
$28.6M
P/E
0.0×
Fwd P/E
—
Dividend yield
—
F-score
4/9
Altman Z
−77.91
Beneish M
n/a
Dividend safety
n/a

Insider Decisions trades per month

Total buys 4.19
Total sells 0.10
Totals in millions of $.
Dec 25 Mar 26 Jun 26 Sep 26
Buy — — — 1 — 1 1 5 1 — 1 2
Sell — — — — — — — — — — 2 —
Insider Ownership 65.53%

Capital & Financial Ratios $m

Market Cap 28.56
Revenue 1.46
Net Income (8.51)
Free Cash Flow (6.89)
Net Debt 0.34
Current Ratio 0.28 (below 1: weak)
Debt/Equity (0.20) (negative: negative equity)
P/E ratio 0.00
Fwd P/E —
P/S ratio 17.98 (above 10: high)
P/B ratio 0.00
Past 5Y EPS Growth —
This Y EPS Growth —
Next Y EPS Growth —
Next Y revenue growth —
Next 5Y EPS Growth —

Green and red mark values outside typical ranges. How we judge →

Valuation vs history

Dividends

Payout Ratio —
Annual Dividend Rate —
Annual Dividend Yield —

Assets vs Liabilities $m

2023 2024 2025 Q'26
Cash 0 3 1 0
Receivables 0 0 0 1
Inventory — — — —
Other — — — —
0 4 2 1
2023 2024 2025 Q'26
Payables 5 6 3 3
ST’ Debt 3 4 1 1
Other 4 3 0 —
14 19 5 5

Compound Annual Growth %

10y 5y 3y
Sales — — 5.63%
Cash Flow — 0.00% 0.00%
Earnings — 0.00% 0.00%
Book Value — 0.00% 0.00%

Revenue $m

Mar Jun Sep Dec Year
’26 0 0 — — —
’25 0 0 0 1 1
’24 0 0 0 0 1
’23 0 0 0 0 1
Fiscal quarters ending in the months shown.

Operating Cash Flow $m

Mar Jun Sep Dec Year
’26 (2) (2) — — —
’25 (2) (2) (2) (2) (8)
’24 (2) (2) (2) (2) (7)
’23 (1) (1) (1) (2) (5)
’22 0 0 0 (4) (5)
’21 — (1) 0 0 0
Fiscal quarters ending in the months shown.

Free Cash Flow $m

Mar Jun Sep Dec Year
’26 (2) (2) — — —
’25 (2) (2) (2) (2) (8)
’24 (2) (2) (2) (2) (7)
’23 (1) (1) (1) (2) (5)
’22 0 0 0 (4) (5)
’22 — — — — (1)
’21 — (1) 0 0 0
Fiscal quarters ending in the months shown.

EPS $

Mar Jun Sep Dec Year
’26 (0.44) (0.37) — — —
’25 (0.56) 0.78 (0.14) (0.71) (0.63)
’24 (0.85) (1.43) (0.70) (0.05) (3.61)
’23 (19.40) (23.81) (32.33) 29.08 (46.46)
’22 6.34 0.06 (0.44) (85.27) (76.63)
’21 0.00 13.45 0.09 — 15.58
Fiscal quarters ending in the months shown.

Target Price Range

Analyst price targets

Recommendation Rating

1Buy 2 3Hold 4 5Sell

Ten years at a glance Fiscal years to December

Group Line 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 Trend 2026e 2027e 2028e
Price, $
Price, $ Low — — — — — 98.10 100.67 6.80 4.20 3.00

Analyst estimates 2026–2028

Powerpack
High — — — — — 102.00 105.60 135.10 33.70 42.20
People
People Employees — — — — — 2 2 20 24 23
Revenue/emp, $m — — — — — 0.00 0.58 0.05 0.03 0.06
Income, $m
Income, $m Revenue — — — — — — 1 1 1 1
Gross margin, % — — — — — — (31.22) (12.63) (43.70) (37.01)
EBT — — — — — 5 (30) (34) (10) (3)
EBT margin, % — — — — — 0.00 (2,639.55) (3,306.76) (1,574.96) (206.03)
Net income — 0 — — — 5 (30) (34) (10) (3)
Depreciation — — — — — — 0 0 0 0
Per share, $
Per share, $ Revenue — — — — — 0.00 2.90 1.40 0.23 0.31
Earnings — — — — — 15.58 (76.63) (46.46) (3.61) (0.63)
Cash flow — — — — — (1.15) (11.83) (6.59) (2.48) (1.68)
Capex — — — — — 0.00 (0.15) (0.06) (0.02) 0.00
Free cash flow — — — — — (1.15) (11.98) (6.65) (2.49) (1.69)
Book value — — — — — (26.12) (66.33) (18.49) (5.68) (0.67)
Shares, m — — — — — 0 0 1 3 4
Valuation, ×
Valuation, × P/E — — — — — — 0.00 0.00 0.00 0.00
P/S — — — — — — 0.00 5.28 59.39 36.06
P/B — — — — — — 0.00 0.00 0.00 0.00
EV/Sales — — — — — — 0.00 9.07 63.06 35.97
EV/FCF — — — — — — (9.08) (1.89) (5.79) (6.50)
Cash, $m
Cash, $m Operating cash flow — — — — — 0 (5) (5) (7) (8)
Capex — — — — — — 0 0 0 0
Free cash flow — — — — — 0 (5) (5) (7) (8)
Balance, $m
Balance, $m Working capital — — — — — 0 (26) (13) (16) (3)
Total debt — — — — — — 2 3 4 1
Net debt — — — — — 0 1 3 1 0
Shareholders’ equity — — — — — (9) (26) (13) (16) (3)
Returns, %
Returns, % ROA — — — — — 4.36 (51.12) (3,853.96) (483.37) (95.30)
ROIC — — — — — 0.00 0.00 0.00 0.00 0.00
ROE — — — — — 10.26 115.76 117.61 68.92 29.62
Negative figures in brackets.

All 10 years →

Fiscal years to Dec 2025 · latest quarter Jun 2026 · fundamentals updated 2 Oct 2026

Charts ten years each

OneMedNet Corporation vs peers in Health Information Services (Q) = latest quarter vs a year earlier

Company Market cap P/E Fwd P/E Revenue growth (Q) EPS growth (Q) FCF growth (Q) Gross margin (Q) EBIT margin (Q) Compare
CCLD CareCloud, Inc. $82.0M 26.4× 12.5× +16.45% (above 0%: growing) n/m +6.15% (above 0%: growing) 45.24% 5.84% Compare
DRIO DarioHealth Corp. $50.3M — (loss-making) — (loss-making) −3.58% (below 0%: shrinking) n/m −0.74% (below 0%: shrinking) 61.66% (125.15%) Compare
ONMD OneMedNet Corporation $28.6M — (loss-making) — +88.39% (above 0%: growing) n/m +14.05% (above 0%: growing) (193.49%) (774.32%)
BEAT HeartBeam, Inc. $24.3M — (loss-making) — — n/m −1.24% (below 0%: shrinking) — 0.00% Compare
RNLXY Renalytix plc - Sponsored ADR $17.2M — (loss-making) — +13.73% (above 0%: growing) n/m +17.96% (above 0%: growing) 19.16% (783.91%) Compare
BFRG Bullfrog AI Holdings Inc. $9.9M — (loss-making) — +2,054.00% (above 0%: growing) n/m −5.67% (below 0%: shrinking) 49.63% (658.82%) Compare
ETAOF ETAO International Co., Ltd. $9.8M — (loss-making) — — n/m +37,595.70% (above 0%: growing) — 0.00% Compare
HCTI Healthcare Triangle, Inc. $7.4M 0.0× — (loss-making) +158.38% (above 0%: growing) n/m +67.48% (above 0%: growing) 22.48% (44.28%) Compare
MGRX Mangoceuticals, Inc. $7.1M — (loss-making) — −59.07% (below 0%: shrinking) n/m +79.27% (above 0%: growing) 64.24% (1,501.45%) Compare
Median of peers $13.6M — — +15.09% — +12.06% 47.44% (84.72%)

All 51 Health Information Services stocks →

OneMedNet Corporation (ONMD) key facts

  • Strength: OneMedNet Corporation’s revenue for fiscal 2025 (year ended December 2025) was $1.4 million, up 111.4% from fiscal 2024.
  • OneMedNet Corporation (ONMD) is a Health Information Services company in the Healthcare sector, listed on Nasdaq.
  • As of October 16, 2026, ONMD traded at $4.51, a market capitalization of $28.6 million.
  • Return on equity was 29.6% and debt-to-equity -0.20.
  • Its Piotroski F-score is 4 out of 9 and its Altman Z-score is −77.91 (distress zone) for fiscal 2025.

Source: company filings (standardised) and stockrow calculations · fundamentals updated Oct 2, 2026.

OneMedNet Corporation (ONMD) Latest News

stockrow.com/ONMD · Data as of Oct 2, 2026 · For information only; not investment advice. · © 2026 stockrow.com